Indaptus Therapeutics, Inc. (INDP)

Indaptus Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	18	15	12	47	14	18
Market Cap Growth	23.07%	23.47%	-74.36%	242.87%	-22.21%	-91.09%
Enterprise Value	9	2	-14	8	13	8
PE Ratio	-	-0.96	-0.84	-6.06	-3.80	-0.37
PB Ratio	1.97	1.22	0.49	1.30	-57.30	1.52
P/FCF Ratio	-1.55	-1.10	-0.93	-4.31	-4.10	-0.58
P/OCF Ratio	-1.55	-1.10	-0.92	-4.14	-4.10	-0.60
EV/EBITDA Ratio	-0.64	-0.10	1.00	-1.00	-3.74	-0.18
EV/EBIT Ratio	-0.64	-0.10	1.00	-1.00	-3.74	-0.18
EV/FCF Ratio	-0.77	-0.12	1.11	-0.71	-4.03	-0.28
Debt / Equity Ratio	0.02	0.01	0.00	0.00	-5.96	0.07
Debt / EBITDA Ratio	-0.01	-0.01	-0.01	-0.02	-0.40	-0.02
Debt / FCF Ratio	-0.01	-0.01	-0.01	-0.02	-0.43	-0.03
Quick Ratio	6.34	4.82	7.70	8.50	0.81	1.21
Current Ratio	6.70	5.05	7.94	8.77	0.86	1.65
Return on Equity (ROE)	-108.10%	-91.80%	-49.40%	-31.10%	-29.70%	-175.90%
Return on Assets (ROA)	-92.90%	-80.40%	-44.20%	-25.30%	-21.00%	-122.40%
Return on Capital (ROIC)	-166.78%	-133.68%	-60.34%	-21.43%	-305.17%	-381.94%
Earnings Yield	-81.20%	-104.31%	-119.61%	-16.51%	-26.31%	-271.84%
FCF Yield	-67.12%	-90.66%	-107.77%	-23.22%	-24.41%	-171.14%
Buyback Yield / Dilution	-0.49%	-1.68%	-101.98%	-110.35%	-360.55%	-8.29%
Total Shareholder Return	-0.49%	-1.68%	-101.98%	-110.35%	-360.55%	-8.29%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).